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A B S T R A C T
Gram-negative bacteria utilize glutathione (GSH) as their major LMW thiol. However, most Gram-positive
bacteria do not encode enzymes for GSH biosynthesis and produce instead alternative LMW thiols, such as
bacillithiol (BSH) and mycothiol (MSH). BSH is utilized by Firmicutes and MSH is the major LMW thiol of
Actinomycetes. LMW thiols are required to maintain the reduced state of the cytoplasm, but are also involved in
virulence mechanisms in human pathogens, such as Staphylococcus aureus, Mycobacterium tuberculosis,
Streptococcus pneumoniae, Salmonella enterica subsp. Typhimurium and Listeria monocytogenes. Infection condi-
tions often cause perturbations of the intrabacterial redox balance in pathogens, which is further aﬀected under
antibiotics treatments. During the last years, novel glutaredoxin-fused roGFP2 biosensors have been engineered
in many eukaryotic organisms, including parasites, yeast, plants and human cells for dynamic live-imaging of the
GSH redox potential in diﬀerent compartments. Likewise bacterial roGFP2-based biosensors are now available to
measure the dynamic changes in the GSH, BSH and MSH redox potentials in model and pathogenic Gram-
negative and Gram-positive bacteria.
In this review, we present an overview of novel functions of the bacterial LMW thiols GSH, MSH and BSH in
pathogenic bacteria in virulence regulation. Moreover, recent results about the application of genetically en-
coded redox biosensors are summarized to study the mechanisms of host-pathogen interactions, persistence and
antibiotics resistance. In particularly, we highlight recent biosensor results on the redox changes in the in-
tracellular food-borne pathogen Salmonella Typhimurium as well as in the Gram-positive pathogens S. aureus and
M. tuberculosis during infection conditions and under antibiotics treatments. These studies established a link
between ROS and antibiotics resistance with the intracellular LMW thiol-redox potential. Future applications
should be directed to compare the redox potentials among diﬀerent clinical isolates of these pathogens in re-
lation to their antibiotics resistance and to screen for new ROS-producing drugs as promising strategy to combat
antimicrobial resistance.
1. Functions of low molecular weight thiols in pathogenic bacteria
1.1. Functions of glutathione in virulence and protein S-glutathionylation in
pathogenic bacteria
Low molecular weight (LMW) thiols play important roles to main-
tain the reduced state of the cytoplasm in all organisms [1,2]. Glu-
tathione (GSH) functions as major LMW thiol in Gram-negative bacteria
and in few Gram-positives, such as Streptococci, Listeria, Lactobacilli and
Clostridia (Fig. 1). However, some Gram-positive pathogens also use
ABC transporters to import GSH either from host cells or from the
growth medium, as shown for Streptococcus pneumoniae and Listeria
monocytogenes [3,4]. The biosynthesis and functions of GSH have been
widely studied in Escherichia coli, which produces millimolar con-
centrations of GSH [2,5]. GSH maintains protein thiols in its reduced
state, functions as a storage form of cysteine and is resistant to metal-
catalyzed autooxidation [2]. GSH undergoes autooxidation 7 times
slower compared to free Cys. Under oxidative stress, GSH is oxidized to
glutathione disulﬁde (GSSG) which is reduced by the glutathione re-
ductase (Gor) on expense of NADPH (Fig. 2). The GSH/GSSG ratio
ranges from 30:1 to 100:1 and the standard thiol-disulﬁde redox po-
tential of GSH was determined as E0'(GSSG/GSH) =− 240mV at
physiological pH values in the cytoplasm of E. coli [1,6]. Many detox-
iﬁcation functions of GSH have been studied in E. coli. GSH is important
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for the defense against redox active compounds, xenobiotics, anti-
biotics, toxic metals and metalloids as reviewed previously [5]. Of note,
GSH is an important cofactor of glyoxalases involved in detoxiﬁcation
of the toxic electrophile methyglyoxal as natural byproduct of the
glycolysis in E. coli [7–10].
Apart from its well-studied detoxiﬁcation functions, GSH con-
tributes to the virulence of important human pathogens. The involve-
ment of GSH in virulence has been studied in the extracellular fa-
cultative anaerobic pathogen S. pneumoniae as well as for the
intracellular food-borne pathogens L. monocytogenes and Salmonella
enterica subsp. Typhimurium (S. Typhimurium) [3,4,11–14]. The glu-
tathione reductase Gor and the GSH-uptake system GshT protect S.
pneumoniae against oxidative stress and toxic metal ions and are re-
quired for colonization and invasion in a mice model of infection [3]. L.
monocytogenes is a facultative intracellular pathogen that has a sapro-
phytic lifestyle in the soil and a parasitic in the host [15]. Speciﬁc
evasion strategies enable to escape the phagolysosome and to pro-
liferate inside the host cell cytosol. L. monocytogenes utilizes host-de-
rived GSH, but can also synthesize bacterial GSH via the GshF fusion
protein [14]. Bacterial and host-derived GSH are both important for
virulence and expression of virulence factors in L. monocytogenes. The
virulence mechanism involves activation of the positive regulatory
factor A (PrfA) by allerosteric binding of GSH as cofactor to PrfA
[13,14] (Fig. 3). PrfA is a member of the CRP/FNR family and the
master regulator for many virulence factors including the actin as-
sembly factor ActA. ActA mediates actin polymerization and is essential
for intracellular spread of the pathogen across host cells [15]. The
structure of the PrfA-GSH complex has been recently determined to
investigate the mechanisms for activation of PrfA upon GSH binding.
GSH binding to a speciﬁc tunnel site of PrfA induces conformational
changes in the tunnel site of PrfA that stabilizes the helix-turn-helix
(HTH) motifs and primes PrfA for binding to the operator DNA [13].
Another structural study of the PrfA-GSH complex suggested that GSH
binding induces local conformational changes in PrfA, allowing DNA
binding and activation of gene transcription [16]. The GSH level and
the reduced cytosol of the host cells further inﬂuence the virulence of L.
monocytogenes [17]. Bacteria cultivated under reducing growth condi-
tions in minimal medium with GSH had a higher PrfA activation state
and virulence factor expression resulting in higher virulence in a
murine infection model [17]. PrfA controls also listeriolysin O (LLO) as
cholesterol-dependent cytolysin (CDC) required for host-cell lysis [15].
Interestingly, LLO was shown to be regulated by S-glutathionylation at
a conserved Cys residue by host and bacterial derived GSH which in-
hibits its hemolytic activity to lyse red blood cells [18]. These two
examples of PrfA and LLO highlight the important roles of GSH in ac-
tivation of virulence factors expression and redox regulation in an im-
portant intracellular pathogen.
The intracellular pathogen S. Typhimurium, which causes gastro-
enteritis, resides inside a Salmonella-containing vacuole (SCV) and in-
jects Salmonella pathogenicity island 2 eﬀectors (SP-2) via a type-III-
secretion system (T3SS) directly into the host cell. S. Typhimurium
encounters oxidative stress by the phagocyte NADPH oxidase (Nox) that
produces Reactive Oxygen Species (ROS) as oxidative burst. Reactive
Nitrogen Species (RNS) are generated by the inducible NO synthase
(iNOS) inside macrophages and neutrophils (Fig. 3). In S. Typhi-
murium, GSH-deﬁcient mutants displayed an increased sensitivity to
ROS and RNS and were attenuated in an acute model of salmonellosis in
NRAMPR mice that produces a high NO level [11]. Thus, GSH is im-
portant for the defense against ROS and RNS produced by Nox and
iNOS as shown in the model of salmonellosis [11]. In addition, GSH was
shown to be required for eﬃcient transcription of the Spi-2 targets
under NO stress. The Spi-2 system interferes with lysosomal traﬃcking
and promotes intracellular replication inside the SCV [19,20]. Spi-2
reduces the contact between Salmonella-containing vacuoles (SCV) and
NADPH phagocyte oxidase vesicles. Thus, Spi-2 protects S. Typhi-
murium against the oxidative burst inside macrophages by maintaining
Fig. 1. Structures of major bacterial low mole-
cular weight (LMW) thiols. The major LMW thiols
are glutathione (GSH) present in Gram-negative
bacteria and few Gram-positive bacteria. Bacillithiol
(BSH) is the major LMW thiol in Firmicutes, such as
Bacillus and Staphylococcus species. Mycothiol (MSH)
is utilized in all Actinomycetes, including myco-
bacteria, corynebacteria and streptomycetes.
Coenzyme A (CoASH) also serves as alternative LMW
thiol-redox buﬀer in S. aureus and B. anthracis.
Ergothioneine (EGT) is a histidine-derived alter-
native LMW thiol in mycobacteria.
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Fig. 2. Reduction of S-glutathionylations, S-bacillithiolations and S-mycothiolations by glutaredoxin, bacilliredoxin and mycoredoxin pathways and design of genetically
encoded Grx1-roGFP2, Brx-roGFP2 and Mrx1-roGFP2 biosensors. The S-glutathionylated proteins are reduced by glutaredoxins (Grx) leading to a Grx-SSG intermediate that is
reduced by GSH and the NADPH-dependent GSSG reductase (Gor). These pathways for reduction of S-glutathionylated proteins are present in E. coli, S. Typhimurium and other Gram-
negative bacteria. Analogous bacilliredoxin and mycoredoxin pathways are present in BSH- and MSH-producing Gram-positive bacteria, such as S. aureus and B. subtilis as BSH producer
and M. tuberculosis and C. glutamicum that utilize MSH. The S-bacillithiolated proteins are reduced by bacilliredoxins (Brx) leading to Brx-SSB formation. The regeneration of Brx-SSB
could require BSH and perhaps the NADPH-dependent pyridine nucleotide oxidoreductase YpdA. In Actinomycetes, mycoredoxin1 (Mrx1) catalyzes reduction of S-mycothiolated proteins
leading to Mrx1-SSM generation that is recycled by MSH and the NADPH-dependent MSSM reductase Mtr. The genetically-encoded biosensors were used to measure the dynamic changes
of the intracellular redox potentials in eukaryotes and Gram-negative bacteria, such as E. coli and S. Typhimurium (Grx1-roGFP2) as well as in the Gram-positive bacteria S. aureus (Brx-
roGFP2) and M. tuberculosis (Mrx1-roGFP2), respectively.
Fig. 3. Functions of GSH in PrfA activation for virulence
factor expression in the intracellular pathogen Listeria
monocytogenes. After phagocytosis by macrophages, the inter-
cellular pathogen L. monocytogenes resides in an oxidizing vacuole
(red), containing ROS and RNS that are produced by Nox and
iNOS. L. monocytogenes has the ability to synthesize GSH, but can
utilize GSH from host cells. In the oxidizing vacuole, GSH pro-
duced by L. monocytogenes is oxidized to GSSG, which does not
bind the PrfA transcription factor [14]. L. monocytogenes escapes
into the reducing host cell cytosol, leading to GSH regeneration
and uptake of GSH from host cells. PrfA binds GSH and activates
transcription of PrfA regulon genes, such as actA. ActA expression
leads to Actin polymerization that allows movement of L. mono-
cytogenes through host cells.
This ﬁgure is adapted from Ref. [14].
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the intracellular thiol-redox balance [12,21]. The importance of this
T3SS Spi-2 for ROS evasion was demonstrated using the roGFP2 bio-
sensor as outlined in the biosensor section [12].
In Yersinia pestis, host-derived GSH functions in S-glutathionylation
of the T3SS eﬀector protein LcrV. Y. pestis causes bubonic plaques as
extraordinary virulence mechanism and employs a T3SS for secretion of
Yop eﬀectors directly into the host cell cytoplasm [22]. These eﬀectors
function in pathogen evasion and neutralization of the host immune
defense. The T3SS ﬁrst secretes the LcrV protein, a plaque-protecting
antigen that forms the needle cap protein of the T3SS and is essential
for plaque pathogenesis [23,24]. LcrV is S-glutathionylated at Cys273
by host-derived GSH after its translocation and S-glutathionylation of
LcrV is important for virulence of Y. pestis [25]. S-glutathionylated LcrV
binds to host ribosomal protein S3 (RPS3), promotes eﬀector secretion
and macrophage killing. In addition, S-glutathionylation of LcrV con-
tributes to bubonic plague pathogenesis in mice and rat models of in-
fections [25]. In conclusion, GSH was shown to control expression and
modiﬁcation of virulence factors that are secreted by the T3SS in bac-
terial pathogens. Moreover, GSH is essential for survival under infection
conditions in diﬀerent pathogens, such as S. pneumoniae, L. mono-
cytogenes and S. Typhimurium.
1.2. Functions of bacillithiol in the virulence and protein S-bacillithiolation
in Gram-positive Firmicutes
The Gram-positive Firmicutes bacteria, such as Bacillus and
Staphylococcus species utilize bacillithiol (BSH, Cys-GlcN-malate) as
their major LMW thiol (Fig. 1) [26,27]. In B. subtilis and S. aureus, BSH
is important for detoxiﬁcation of many redox-active compounds. BSH-
deﬁcient mutants showed growth and survival defects after treatment
with ROS, electrophiles, HOCl, toxins, alkylating agents, heavy metals
and redox-active antibiotics, such as fosfomycin and rifampicin
[28–30]. BSH functions as cofactor for thiol-dependent detoxiﬁcation
enzymes, such as thiol-S-transferases (FosB) and glyoxalases (GlxA/B).
These thiol-dependent enzymes conjugate BSH to toxic electrophiles,
fosfomycin and methylglyoxal for its detoxiﬁcation [28,31]. BSH has
also an impact on metal homeostasis and functions in Zn2+-storage, FeS
cluster assembly and copper buﬀering [32–35]. The standard thiol-
redox potential of BSH was calculated as E0'(BSSB/BSH) =− 221mV
and the BSH/BSSB ratios were determined as 100:1–400:1 under con-
trol conditions in B. subtilis cells [35–37]. Under NaOCl stress, the BSSB
level is increased indicating a more oxidized BSH redox potential [38].
The NADPH-dependent pyridine nucleotide disulﬁde reductase YpdA is
supposed to functions as BSSB reductase (Fig. 2), but its role in re-
generation of BSH has not been demonstrated.
Of note, BSH has an important role for virulence in the major pa-
thogen S. aureus. BSH protects S. aureus under infection-like conditions
in phagocytosis assays using human and murine macrophages [29,30].
The survival of BSH-minus clinical MRSA strains was strongly impaired
in human whole-blood survival assays [29]. The exact protective role of
BSH inside the host is unknown, but the yellow antioxidant pigment
staphyloxanthin was present at lower amounts in the absence of BSH
[29]. S. aureus isolates carry many mobile genetic elements, such as
prophages, pathogenicity islands, transposons and plasmids explaining
their high genome diversity. Due to a former transposon or other in-
sertion element, S. aureus NCTC8325 derivatives (e.g. SH1000) are bshC
mutants and do not produce BSH [29,30,39]. Thus, also S. aureus
SH1000 was impaired in survival inside murine macrophages and
human epithelial cells and the phenotype could be restored by com-
plementation with plasmid-encoded bshC [29,30]. Thus, BSH functions
as virulence mechanism in the defense against the host immune system
in S. aureus clinical isolates. Macrophages and neutrophils produce
large quantities of ROS and HOCl as well as bactericidal ammonium
chloramines during the oxidative burst [40–42]. Thus, the defense
mechanism of BSH could involve regulatory mechanisms by formation
of BSH mixed protein disulﬁdes (S-bacillithiolations) in S. aureus inside
neutrophils and macrophages.
To get insights into the targets for S-bacillithiolations in S. aureus
under infection-like conditions, we have studied the quantitative thiol-
redox proteome of S. aureus USA300 under NaOCl stress using the
OxICAT approach [43]. In total, 58 Cys residues with> 10% increased
thiol-oxidation could be quantiﬁed under NaOCl stress. In addition, ﬁve
S-bacillithiolated were identiﬁed in S. aureus under NaOCl stress by
shotgun proteomics. These S-bacillithiolated proteins showed the
highest oxidation increase of> 29% in the OxiCAT analysis. The gly-
ceraldehyde-3-phosphate dehydrogenase Gap was identiﬁed as most
abundant S-bacillithiolated protein representing 4% of the total Cys
abundance in the proteome. Protein S-bacillithiolation functions in
redox regulation and protects the active site Cys151 of S. aureus Gap
under H2O2 and NaOCl stress against overoxidation in vitro [43]. Future
studies should reveal whether S-bacillithiolation of Gap or other pro-
teins could provide protection of S. aureus under infection conditions
inside macrophages and neutrophils. This adaptation to infection con-
ditions in S. aureus could involve the metabolic re-conﬁguration of
central carbon metabolism as shown in eukaryotic organisms [44,45].
In yeast cells, Gap oxidation has been linked to the re-direction of the
glycolytic ﬂux into the pentose phosphate pathway (PPP) to increase
NADPH levels. NADPH is used as electron donor for thioredoxin and
glutathione reductases to recover from oxidative stress [44,45]. Similar
mechanisms could be relevant also for S. aureus to enhance survival
under infection conditions.
Apart from BSH, S. aureus produces also coenzymeA (CoASH) as
abundant alternative LMW thiols and essential cofactor in cellular
metabolism. Moreover, a CoASH disulﬁde oxidoreductase (Cdr) is en-
coded in the genome of S. aureus that could be involved in reduction of
CoAS disulﬁdes [27]. However, the functions of CoASH and Cdr for the
redox regulation of proteins by CoA-thiolations are unknown in S.
aureus. Recently, CoA-thiolation was shown in mammalian cells as a
widespread post-translational redox modiﬁcation under oxidative stress
[46]. Numerous Cys peptides with CoA-thiolation sites were detected in
H2O2-treated heart cells and in the mitochondria of liver cells from
starved rats [46]. The authors developed a monoclonal antibody for
enrichment of CoA-thiolated proteins and identiﬁed 80 CoA mixed
disulﬁdes (58 proteins) in heart cells and 43 CoA-thiolated Cys peptides
(33 proteins) in liver cells using mass spectrometry. Many CoA-thio-
lated proteins function in main metabolic pathways, like the TCA cycle
and the beta-oxidation pathway of fatty acids. These pathways involve
activated CoA-derivatives, such as acetyl-CoA indicating that CoA me-
tabolism and CoA-thiolation are functionally connected. It was also
demonstrated that CoA-thiolation can inactivate enzymes and function
in redox regulation of the glycolytic GapDH, the isocitrate dehy-
drogenase IDH and other metabolic enzymes [46]. Thus, it will be in-
teresting to reveal if GapDH and other S-bacillithiolated proteins are
also targets for CoA-thiolation in S. aureus under NaOCl stress.
The reduction of S-bacillithiolated proteins is catalyzed by ba-
cilliredoxins (BrxA and BrxB) that belong to DUF1094 family. Brx
proteins possess an unusual CGC motif, but function similar like glu-
taredoxins in B. subtilis and S. aureus (Fig. 2) [43,47]. Thus, Brx of S.
aureus has been used to construct the ﬁrst Brx-roGFP2-fused biosensor
to measure changes in the BSH redox potential in S. aureus under oxi-
dative stress and infection conditions inside human macrophages as
outlined in the biosensor section.
1.3. Functions of mycothiol in the virulence and protein S-mycothiolation in
Actinomycetes
Mycothiol (MSH; NAc-Cys-GlcNAc-myoinositol) is the major LMW
thiol in high-GC Gram-positive Actinomycetes, including Streptomycetes,
Mycobacterium and Corynebacterium species (Fig. 1) [48,49]. Under
oxidative stress, MSH is oxidized to MSH disulﬁde (MSSM) and main-
tained in a reduced state by the mycothiol disulﬁde reductase Mtr. MSH
is involved in detoxiﬁcation of numerous compounds, such as ROS,
Q.N. Tung et al. Free Radical Biology and Medicine 128 (2018) 84–96
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RES, alkylating agents, toxins, antibiotics (erythromycin, vancomycin,
rifampin, azithromycin), heavy metals and toxic metalloids, aromatic
compounds, ethanol and glyphosate as studied in diﬀerent Actinomy-
cetes [48,50–53]. In Streptomyces lincolnensis, MSH participates in the
biosynthesis of the sulfur-containing antibiotics lincomycin [54]. For
more details of these many detoxiﬁcation functions of MSH and MSH-
dependent enzymes, the reader is referred to previous and recent re-
views [28,55].
Under hypochlorite stress, MSH was shown to form mixed disulﬁdes
with protein thiols, termed as protein S-mycothiolation [56–58]. Pro-
tein S-mycothiolation protects protein thiols against the formation of
sulﬁnic and sulfonic acids and regulates protein activities, as demon-
strated in Corynebacterium glutamicum, Corynebacterium diphtheriae and
Mycobacterium smegmatis. About 25 S-mycothiolated proteins were
identiﬁed in C. glutamicum [56], 26 proteins in C. diphtheriae [58] and
58 in M. smegmatis under NaOCl stress [57]. Among the S-mycothio-
lated proteins, several are conserved S-thiolated at their active sites Cys
residues in diﬀerent Gram-positive bacteria, including thiol-perox-
idases/peroxiredoxins (Tpx, AhpC), ribosomal proteins (RpsM, RplC),
the IMP dehydrogenase (GuaB), the myo-inositol-1-phosphate synthase
(Ino1), the methionine synthase (MetE) and the glycolytic GapDH
[38,56]. The extend of protein S-mycothiolation correlates with the
diﬀerent MSH levels in corynebacteria and mycobacteria [59]. While
M. smegmatis contains 6 µmol/g raw dry weight (rdw) MSH [57], only
0.3 µmol/g rdw were determined in C. diphtheriae [58]. Thus, cor-
ynebacteria most likely utilize also alternative LMW thiols which re-
mains to be investigated.
Mycobacteria utilize the histidine-derivative ergothioneine (EGT) as
another alternative LMW thiol. MSH and EGT are both required for full
virulence and redox homeostasis of Mycobacterium tuberculosis (Mtb)
[60,61]. Both LMW thiols contribute also to full peroxide resistance of
M. smegmatis [62]. EGT levels are even increased in the mshA mutant
conﬁrming that EGT can compensate for the absence of MSH [63]. Our
redox proteomics studies revealed an increased thiol-oxidation level in
the M. smegmatis mshC mutant which could involve alternative S-er-
gothionylation which remains to be elucidated [57]. However, in con-
trast to MSH, EGT is actively secreted into the supernatant [62]. Future
studies should be directed to study the role of EGT secretion in reg-
ulation of EGT levels, modulation of host ROS levels and S-thiolation of
bacterial and host proteins during infections.
Protein S-mycothiolation is redox-regulated by both, the mycor-
edoxin and thioredoxin pathways as demonstrated for thiol peroxidases
(Tpx, Mpx, AhpE), the methionine sulfoxide reductase (MsrA) and the
glycolytic GapDH in vitro [56,58,64–66]. Reduction of S-mycothiolated
GapDH occurred much faster by Mrx1 compared to Trx in vitro in-
dicating that Mrx1 is probably the main de-mycothiolating enzyme in
vivo [58]. In addition, S-mycothiolation of GapDH is faster compared to
its overoxidation in vitro. The methionine synthase MetE was further
protected by S-mycothiolation under acid stress conditions in C. gluta-
micum [67]. These results indicate that S-mycothiolation can eﬃciently
protect the active site Cys residues against overoxidation to sulﬁnic or
sulfonic acids and can be reversed by both, the Mrx1 and Trx pathways.
Mrx1 was used to construct the ﬁrst MSH speciﬁc genetically encoded
biosensor Mrx1-roGFP2 to measure changes in the MSH redox poten-
tial.
Apart from S-mycothiolation, MSH plays also an important role for
growth, survival and antibiotics resistance under infection conditions in
the major pathogen Mtb [61,68]. Mtb is the etiologic agent of tu-
berculosis (TB) disease resulting in about 2 million human death each
year [69]. Due to the slow intracellular growth of Mtb inside the pha-
gosomes of macrophages, TB patients have to be treated with anti-
biotics for several months, resulting in multiple and extreme drug re-
sistant Mtb isolates (MDR/XDR) as a major health burden. MSH is
involved in the activation of the ﬁrst-line anti-TB drug isoniazid (INH)
inMtb [70]. INH is a pro-drug that is activated by the catalase KatG and
MSH resulting in a NAD-INH adduct that ﬁnally inhibits InhA of the
mycolic acid biosynthesis pathway [71]. Thus, the evolved INH re-
sistant Mtb isolates often carry spontaneous mutations in katG, mshA
and in the target gene inhA [51]. This requires alternative drug devel-
opments to treat emerging resistant Mtb isolates. Since MSH is im-
portant for virulence of Mtb, inhibitors of MSH biosynthesis and re-
cycling have been successfully applied in combination therapies that
target MshB, MshC, Mtr and the MSH-S-conjugate amidase Mca as new
anti-TB drugs [72]. Moreover, ROS-producing compounds have been
designed and may have a great potential to tackle anti-tuberculosis
drug resistance. In the later sections, we will highlight recent work in
drug research showing the power of the genetically encoded Mrx1-
roGFP2 biosensor to study the role of MSH in antibiotics resistance, to
reveal the involvement of ROS in the killing mode of antibiotics under
infection conditions and to develop new combination therapies invol-
ving ROS-producing compounds.
2. Dynamic redox potential measurements using roGFP2-based
biosensors in pathogens
The development of redox-sensitive green ﬂuorescent proteins
(roGFPs) has enabled the ratiometric measurement of the cellular redox
potential at high sensitivity and spatiotemporal resolution using live-
imaging approaches [73–76]. For construction of roGFPs, two redox-
active Cys residues (Cys147 and Cys204) were introduced in the GFP
molecule that form a disulﬁde bond upon oxidation resulting in con-
formational changes of the chromophore and ﬂuorescence changes
[76]. The roGFP2 biosensor has two excitation maxima at 405 and
488 nm, which change upon oxidation resulting in a ratiomeric bio-
sensor response [74,77]. The Cys pair in roGFPs has been shown to
equilibrate with the GSH/GSSG redox couple and the probes are widely
used to measure the changes in the GSH redox potential in living eu-
karyotic cells [76]. However, the equilibration of endogenously ex-
pressed roGFPs with the GSH/GSSG pair is too slow and limited by the
Grx expression levels. The Grx levels vary also in diﬀerent compart-
ments and are rate-limiting factors in the thiol-disulﬁde exchange re-
actions between the probe and the GSH pool.
To facilitate the speciﬁc response of roGFP2 with the GSH/GSSG
redox couple, human glutaredoxin was fused to roGFP2 to construct the
Grx1-roGFP2 biosensor for real-time measurements of the dynamic
changes in the GSH redox potential (EGSH) in eukaryotic organisms
[75]. The Grx1-roGFP2 biosensor responds much faster within seconds
to nanomolar concentrations of GSSG compared to unfused roGFP2
[74,75]. Thus, the Grx1-roGFP2 probe is highly speciﬁc and detects
small changes in the GSH redox potential in living eukaryotic cells. To
date, roGFP2 and Grx1-roGFP2 biosensors have been applied in many
eukaryotic organisms and pathogens to study intracellular redox
changes in Arabidopsis thaliana, Caenorhabditis elegans [75,78,79], yeast
cells and the malaria parasite Plasmodium falciparum [80]. In particu-
larly, pathogens are well suited to analyze the eﬀect of drugs on the
cellular redox metabolism and hence, the biosensors can help to screen
for novel ROS-producing drugs. In this part of the review, we will
present an overview about the application of roGFP2 biosensors in
major human pathogens, including the foodborne intracellular pa-
thogen S. Typhimurium, the extracellular Gram-positive pathogen S.
aureus and in the intracellular major pathogen M. tuberculosis. Alto-
gether, the biosensor results have advanced our understanding of the
mechanisms of survival and intracellular replication, ROS evasion and
persistence as well as antibiotics resistance in many important human
pathogens.
2.1. Dynamic roGFP2-based biosensors to measure redox changes in Gram-
negative bacteria
The roGFP2 biosensors were ﬁrst applied in Gram-negative bacteria
to measure the redox changes during growth, under oxidant and anti-
biotics treatment as well as infection conditions. In E. coli, plasmid-
Q.N. Tung et al. Free Radical Biology and Medicine 128 (2018) 84–96
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encoded roGFP2 was used to observe cellular oxidation in response to
diﬀerent oxidants, toxic heavy metals and metalloids [81,82]. Toxic
biocides, pollutants and metalloids are often found as environmental
contaminants and originate from anthropogenic and natural sources.
Thus, roGFP2 served as diagnostic tool to measure oxidative stress in E.
coli by toxic environmental contaminants. Low levels of 0.1–1mM H2O2
resulted in a rapid roGFP2 biosensor response. The roGFP2 biosensor
showed also a fast response to heavy metals, such as Cd2+, Zn2+, Cu2+,
Pb2+, arsenite and selenite as well as biocides and redox-cycling agents
(menadione, naphthalene). However, quantiﬁcation of the biosensor
response using the microplate reader was not possible after exposure to
toxic heavy metals or metalloids due to instability of the roGFP2 bio-
sensor [81]. To increase roGFP2 stability, E. coli cells expressing the
roGFP2 biosensor were immobilized in a transparent k-carrageenan
(KC) matrix for further toxicity measurements [83]. The detection limit
to measure a biosensor response was deﬁned as 0.2 µg/l for arsenite and
5.8 ng/l for selenite. These immobilized roGFP2 expressing E. coli cells
were applied to screen for bioavailability and toxic eﬀects of pollutants
[83].
2.1.1. The T3SS Spi-2 contributes to ROS evasion in S. Typhimurium
The ﬁrst physiological studies in pathogenic Gram-negative bacteria
using roGFP2 biosensors were performed in the intracellular pathogen
S. Typhimurium that replicates inside the SCV [12]. S. Typhimurium
escapes ROS by the T3SS Spi-2 that injects eﬀectors directly into the
host cell cytoplasm (Fig. 4). Thus, the biosensor was used to elucidate
whether the T3SS Spi-2 contributes to evasion from the host innate
immune defense to escape ROS and RNS. The intrabacterial redox
changes were measured in S. Typhimurium after infection of HeLa cells
and THP-1 cells that produce diﬀerent ROS levels. In addition, the in-
ﬂuences of the Spi-2 system and its eﬀector SifA on ROS evasion stra-
tegies were investigated using ssaR and sifA mutants which are re-
viewed in this part.
S. Typhimurium encounters an acidic environment inside macro-
phages. Thus, it was ﬁrst conﬁrmed that the puriﬁed roGFP2 probe is
not pH-sensitive in vitro. Next, the biosensor response inside S.
Typhimurium cells was measured after treatment with H2O2 and the
NO donor SpermineNONOate since S. Typhimurium has to cope with
ROS and RNS that are produced by Nox and iNOS after phagocytosis.
The roGFP2 biosensor responds very fast and reversible to 50–500 µM
H2O2, but only high concentrations of 25mM H2O2 lead to full oxida-
tion of the probe inside S. Typhimurium. However, due to the
detoxiﬁcation by catalases and peroxidases, cells could quickly re-
generate the reduced state even after treatment with high H2O2 levels.
In contrast, exposure to 5–20mM of the NO-donor resulted in a strongly
increased biosensor oxidation with no recovery of the reduced state.
These experiments veriﬁed that the probe detects intrabacterial redox
changes under physiological micromolar ROS and RNS challenge.
To analyze the redox changes in S. Typhimurium after infection of
host cells, epithelium-like HeLa cells and macrophages-like THP-1 cells
were used. Interestingly, S. Typhimurium replicating inside THP-1 cells
experienced higher levels of redox stress compared to bacteria infected
in HeLa cells. The THP-1 cell line is known to produce higher ROS le-
vels and is able to kill the majority of S. Typhimurium cells [12].
Moreover, redox stress heterogeneity was observed between diﬀerent S.
Typhimurium cells that maybe important to understand persistence and
antibiotic resistance mechanisms.
In human and murine macrophages it was further shown that S.
Typhimurium cells experience more redox stress in the cytosol com-
pared to that residing in the SCV indicating that replication inside the
vacuole contributes to ROS evasion. Thus, the role of the T3SS Spi-2 as
ROS evasion strategy inside the SCV was investigated in the ssaR mu-
tant that lacks the functional Spi-2 system (Fig. 4) [12]. The ssaR mu-
tant displayed a higher oxidation level in THP-1 cells compared to the
wild type indicating that the Spi-2 system contributes to ROS evasion.
Previous studies revealed that Spi-2 eﬀectors aﬀect co-localization of
SCV and phagocyte Nox vesicles, which contributes to ROS evasion
[12,21]. Among the Spi-2 eﬀectors, SifA was shown to control vacuole
integrity as ROS evasion strategy. The biosensor measurements re-
vealed that ROS evasion by the Spi-2 system requires an intact SCV
since the sifA mutant experienced a higher redox stress [12]. Thus, the
Spi-2 system functions via its eﬀector SifA in ROS evasion to maintain
the reduced state of the cytoplasm and to allow intracellular survival of
S. Typhimurium [12].
2.1.2. Regulation of H2O2 detoxiﬁcation and ROS-generation by antibiotics
and toxic metals
Bacteria have evolved diﬀerent antioxidant enzymes for ROS de-
toxiﬁcation, such as catalases, thiol-dependent peroxidases, peroxir-
edoxins and superoxide dismutase [84]. The role of many H2O2
scavenging enzymes is often unknown in bacteria [85] and hence
roGFP2 biosensors can contribute to study the dynamics and activity of
ROS-degradation by the diﬀerent bacterial enzymes. Thus, the roGFP2
biosensor was applied to measure redox changes and the ROS
Fig. 4. Mechanisms of ROS evasion allowing intracellular
replication of Salmonella Typhimurium inside the SCV to es-
cape the host immune defense as revealed by the roGFP2
biosensor. The intracellular pathogen S. Typhimurium produces
GSH and replicates inside macrophages in a Salmonella-containing
vacuole (SCV). S. Typhimurium escapes ROS in the SCV by the
type-III-secretion system Spi-2 that injects eﬀectors directly into
the host cell cytoplasm. GSH is required for transcription of the
Spi-2 targets under NO stress. S. Typhimurium cells are highly
reduced (green) inside in the SCV, while those that escape into
host cells cytoplasm are oxidized [12]. The Spi-2 eﬀector SifA
aﬀects co-localization of SCV and Nox vesicles and controls the
vacuole integrity via microtubuli formation, which contributes to
ROS evasion [12]. The Spi-2 eﬀectors also interfere with lyso-
somal traﬃcking, promoting intracellular replication inside the
SCV [19,20]. Thus, the Spi-2 system via its eﬀector SifA functions
in ROS evasion, controls vacuole integrity and maintains the in-
tracellular redox balance of S. Typhimurium inside the SCV to
allow intracellular replication [12].
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detoxiﬁcation capacity after treatment with H2O2, toxic heavy metals
and antibiotics across diﬀerent Gram-negative bacteria, including non-
pathogenic and pathogenic E. coli, Citrobacter rodentium, Yersinia pseu-
dotuberculosis, Salmonella enterica serovar Typhi and S. Typhimurium
[86]. Using speciﬁc mutants in catalases and peroxidases, the kinetics
of H2O2 detoxiﬁcation was monitored for each antioxidant enzyme in
diﬀerent bacteria. Although the bacterial species were evolutionary
related, the activities of their H2O2 detoxiﬁcation enzymes showed
strong variations. This enabled also to measure the ROS detoxiﬁcation
capacity of S. Typhimurium during priming with sub-lethal doses of
500 µM H2O2 and subsequent challenge with higher doses of 1mM
H2O2 compared to naïve cells. The primed bacteria could faster detoxify
1mM H2O2 and recover to the reduced state compared to naïve bacteria
[86].
In S. Typhimurium, the biosensor further allowed to measure en-
dogenous ROS production in a catalase/peroxidase-negative hpxf mu-
tant during diﬀerent growth phases, media and temperatures. The en-
dogenous ROS levels were highest during the later exponential growth
at 37 °C in rich media compared to minimal medium. Thus, optimal
growth conditions that allow a maximum growth rate correlate with
high oxygen consumption and increased ROS generation. Similar as in
the ﬁrst E. coli roGFP2 approach [83], the toxicity of metals was as-
sessed due to ROS production using the biosensor in S. Typhimurium
[86]. While certain metal ions are required for H2O2 detoxiﬁcation,
exposure of S. Typhimurium to zinc and nickel contributed to ROS
generation by inhibition of ROS detoxiﬁcation enzymes (zinc) or
spontaneous thiol-oxidation (nickel).
Next, biosensor measurements were performed under antibiotics
treatment to validate whether ROS are involved in the killing mode of
antibiotics, a continuous and controversial debate among micro-
biologists [87–89]. The oxidation-sensitive S. Typhimurium hpxf mu-
tant was exposed to diﬀerent antibiotics classes, including aminogly-
cosides, quinolones, cephalosporine and β-lactam antibiotics, but no
increased biosensor oxidation could be monitored. This indicates that
these antibiotics classes do not enhance endogenous ROS as killing
mode in the S. Typhimurium hpxf mutant [86]. In contrast, Shukla and
coworkers [90] showed that exposure to ampicillin, amikacin and ci-
proﬂoxacin leads to an impaired redox balance and increased biosensor
oxidation in E. coli. Moreover, hydrogen persulﬁde (H2S) was shown to
protect E. coli against oxidative stress triggered by bactericidal anti-
biotics which is controlled by two mechanisms. H2S mediated antibiotic
tolerance involves rerouting of the electron ﬂow from the energy-eﬃ-
cient cytochrome bo oxidase (Cyo) to the less-energy eﬃcient cyto-
chrome bd oxidase (CydBD) to maintain the respiratory ﬂux and the
redox balance. In addition, H2S enhances the activities of the anti-
oxidant enzymes catalase and superoxide dismutase which contributes
to ROS detoxiﬁcation under antibiotics treatments [90].
In S. Typhimurium, the roGFP2 biosensor was further applied to
determine the real-time H2O2-inﬂux [91]. The H2O2-inﬂux was calcu-
lated by multiplication of the membrane permeability coeﬃcient (P),
the membrane surface area (A) and the diﬀerence between the inner
and outer H2O2 concentrations (ΔC) as revealed by the degree of bio-
sensor oxidation. The results showed that H2O2 ﬁrst enters the cells by
passive diﬀusion which is suddenly stopped, also termed as “switching
point”. This stop in the H2O2 inﬂux was caused by changes in the outer
membrane permeability, as veriﬁed by spheroplasts lacking an outer
membrane. The spheroplasts exhibited a signiﬁcantly faster H2O2-inﬂux
without the “switching point”. The outer membrane proteins OmpA and
OmpC were shown to regulate the H2O2 inﬂux by opening and closing
of their beta barrel structures [91].
Altogether, the roGFP2 biosensor has been widely used to measure
the intrabacterial redox changes in several Gram-negative bacteria
during the growth and under treatment with ROS and redox-active
compounds, such as toxic metals and antibiotics as well as during in-
fection and intracellular replication. The results revealed surprising
diﬀerences in the H2O2 detoxiﬁcation kinetics by antioxidant enzymes,
such as catalases and peroxidases across closely related bacteria.
Diﬀerent antibiotics did not caused increased ROS-formation in a S.
Typhimurium ROS-sensitive mutant [86], while Shukla and coworkers
[90] revealed enhanced roGFP2 oxidation by antibiotics in E. coli cells.
These diﬀerent studies using the same roGFP2 biosensors further con-
tribute to the controversial debate about the involvement of ROS in the
killing mode of antibiotics. Moreover, roGFP2 biosensor measurements
revealed that H2O2-inﬂux is regulated by switching point due to OMPs
that can open and close their beta-barrel. Of particular importance are
further the roGFP2 biosensor measurements of S. Typhimurium inside
the SCV. It was shown that the type-III-secretion system Spi-2 is re-
quired for ROS evasion and this depends on an intact vacuole. The
bacteria were protected against ROS inside the SCV while bacteria that
escaped into the host cell cytoplasm were more oxidized by ROS.
However, as critical remark, it has to be mentioned that the authors
used only uncoupled roGFP2 for all measurements of the intrabacterial
redox potential in S. Typhimurium. The unfused roGFP2 biosensor
suﬀers from its low speciﬁcity for the GSH/GSSG redox couple and the
limited availability of endogenous Grx. Thus, whether the roGFP2
probe speciﬁcally responds to GSH redox potential changes or other
redox signals is not known. Future studies should be performed using
the Grx1-roGFP2 biosensor which is highly speciﬁc to measure ratio-
metric changes in the GSH redox potential [75]. It will be also inter-
esting to apply the Grx1-roGFP2 biosensor to study the mechanisms of
ROS evasion in other GSH-utilizing intracellular pathogens, such as L.
monocytogenes and Legionella pneumophila.
2.2. Dynamic measurement of the BSH redox potential (EBSH) using the
Brx-roGFP2 biosensor in the human pathogen S. aureus
We have recently fused bacilliredoxin (Brx) of S. aureus to roGFP2 to
construct the ﬁrst genetically encoded Brx-roGFP2 biosensor for dy-
namic measurement of the intracellular BSH redox potential (EBSH) in S.
aureus [92]. The BSH redox potential changes were determined during
the growth, under ROS and NaOCl stress, during infection inside THP-1
macrophages and antibiotics treatments in two clinical MRSA isolates
COL and USA300. In both MRSA strains, BSH enhances the survival
during phagocytosis with human and murine macrophage-like cell lines
[29,30]. Brx-roGFP2 is highly speciﬁc for physiological levels of
10–100 µM BSSB which depends on the Brx active site Cys in vitro. Thus,
Brx-roGFP2 facilitates rapid equilibration of the biosensor with the
BSH/BSSB couple to determine the changes in the BSH redox potential
inside S. aureus.
First, an increased biosensor oxidation was measured in S. aureus
COL and USA300 in rich medium during the stationary phase compared
to the log phase. The dynamic range of Brx-roGFP2 was higher in COL
compared to USA300, which may depends on their diﬀerent BSH levels
[29]. USA300 is a highly virulent CA-MRSA strain, which produces
many unique virulence factors encoded on prophages, pathogenicity
islands and other mobile genetic elements [93]. In addition, USA300
has a higher level of BSH compared to COL. Thus, the biosensor re-
sponse of USA300 could be lower under diamide stress resulting in a
lower dynamic range of fully reduced versus oxidized probes. In addi-
tion, strain USA300 could be less permeable or more resistant to dia-
mide compared to COL, leading only to partial biosensor oxidation.
Future studies should involve other strong oxidants, such as cumene
hydroperoxide or redox cycling agents for full oxidation of the bio-
sensor to increase the dynamic range in USA300.
Treatment of S. aureus COL with diﬀerent oxidants resulted in a fast
biosensor response, but at diﬀerent oxidation degrees. While doses of
50–100 µM NaOCl stress lead to the fully oxidation of the biosensor,
exposure of S. aureus to 1–10mM H2O2 revealed only a slightly in-
creased oxidation degree with rapid regeneration of the reduced state.
This lower biosensor response under H2O2 stress might be due to the
high H2O2 resistance of S. aureus which is able to survive up to 300mM
H2O2 [94]. We further measured the changes in BSH redox potential
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inside S. aureus COL after infection of THP-1 macrophages using ﬂow
cytometry. The Brx-roGFP2 biosensor was 87% oxidized in S. aureus
COL inside macrophages indicating that S. aureus experiences oxidative
stress after internalization. In future studies, the redox dynamics of
persister cells inside macrophages should be investigated to reveal the
BSH redox dynamics during internalization, which is often the cause of
chronic S. aureus infections.
The biosensor response was also measured in S. aureus COL and
USA300 bshA mutants and in RN4220, which is a natural bshC mutant
of the NCTC8325-4 lineage. Brx-roGFP2 was fully oxidized in the BSH-
deﬁcient mutants indicating an impaired redox balance in the absence
of BSH. In previous studies, a lower NADPH level was found in the bshA
mutant perhaps explaining its impaired redox balance [29]. To clarify
whether ROS generation contributes to the killing mode of antibiotics,
S. aureus was exposed to sub-lethal doses of diﬀerent antibiotics classes,
including rifampicin, fosfomycin, ampicillin, oxacillin, vancomycin,
aminoglycosides and ﬂuoroquinolones. However, no increased oxida-
tion degree of the Brx-roGFP2 biosensor was measured under anti-
biotics treatment, which conﬁrms the ﬁndings in S. Typhimurium [86].
However, the biosensor responds fast to oxidants and could be a valu-
able tool in drug-research to screen for new ROS-generating antibiotics
that aﬀect the BSH redox potential in S. aureus. Future studies should be
directed to measure the ROS detoxiﬁcation capacity in mutants lacking
antioxidant systems and in MRSA-isolates of various genetic lineages to
unravel the link between ROS resistance and the BSH redox potential in
S. aureus.
2.3. Dynamic measurements of the MSH redox potential (EMSH) in
Mycobacterium tuberculosis using the Mrx1-roGFP2 biosensor
In Mtb, an analogous Mrx1-roGFP2 biosensor was developed for
dynamic measurements of the MSH redox potential (EMSH) in drug-re-
sistant isolates and inside the acidic phagosomes of macrophages
[74,95,96]. The increasing prevalence of persistent and chronic relap-
sing Mtb infections as well as multiple and extreme drug-resistant
(MDR/XDR) Mtb isolates are a major health burden. Thus, the devel-
opment of new drugs against severe tuberculosis infections is an urgent
need. The new biosensor was successfully applied to screen for ROS-
generating anti-TB drugs and combination therapies (e.g. augmentin or
isoniazid combinations) that aﬀected EMSH to study drug actions linked
to the EMSH to combat life-threatening TB infections [95,97–99]. It was
revealed that the EMSH inside infected macrophages is heterogeneous
with sub-populations that have reduced, oxidized and basal levels of
EMSH. This redox heterogeneity depends on sub-vacuolar compartments
inside macrophages and the cytoplasmic acidiﬁcation that requires
WhiB3 as central redox regulator [95,96]. These results using the Mrx1-
roGFP2 biosensor have advanced the understanding how this major
pathogen copes with anti-TB drug and persists inside macrophages. The
major results obtained with Mrx1-roGFP2 are summarized in this part
of the review.
After construction of the Mrx1-roGFP2 biosensor, it was demon-
strated that the Mrx1-roGFP2 fusion is speciﬁc to measure MSSM, but
does not respond to other LMW thiol-disulﬁdes [95]. It was further
controlled that overexpression of Mrx1-roGFP2 does not aﬀect cellular
metabolism, stress resistance and the basal level of EMSH in Mtb [95].
Importantly, diﬀerences were observed in the biosensor response be-
tween slow growingMtb strains and fast growingM. smegmatis resulting
in a delayed response to H2O2 in Mtb and a rapid H2O2 response in M.
smegmatis [95]. However, there was only little variation between the
basal EMSH in various drug-resistant (MDR/XDR) and drug-sensitive
clinical Mtb isolates during laboratory growth, where the intracellular
EMSH was calculated as highly reduced with values of − 273mV to
− 280mV [95]. However, in slow growingMtb strains the EMSH is more
oxidizing compared to fast growing M. smegmatis. In M. smegmatis, a
basal EMSH of − 300mV was calculated which is consistent with the
higher MSH/MSSM ratio (200:1) in M. smegmatis compared to that in
Mtb (50:1) [100].
2.3.1. EMSH redox heterogeneity in Mtb sub-populations depends on speciﬁc
vacuole compartments
In general, diﬀerent Mtb strains did not show strong variations in
their intracellular EMSH when grown under in vitro conditions in growth
media. However, this was completely diﬀerent under in vivo infection
conditions. Diﬀerent Mtb sub-populations with reduced (− 300mV),
oxidized (− 240mV) and basal EMSH (− 270mV) could be observed
and quantiﬁed by ﬂow cytometry under infection conditions inside
THP-1 macrophages [95]. It was further shown that the reduced EMSH
sub-population is decreased and the oxidized EMSH sub-population is
increased at later time points of macrophage infections which correlates
with a decreased MSH/MSSM ratio [95]. Thus, the intramacrophage
Fig. 5. The role of EMSH and the WhiB3 transcription factor in
M. tuberculosis persistence under acidic conditions during
infection of macrophages as shown by the Mrx1-roGFP2
biosensor. M. tuberculosis is an intracellular pathogen that re-
plicates inside the acidic phagosome of macrophages (pH ~ 6.2)
preventing phagosomal maturation to phagolysosomes as survival
mechanism. During immune activation of macrophages, phago-
somes are fused with lysosomes resulting in further pH decrease
to pH 4.5. The mild acidiﬁcation in phagosomes causes a highly
reduced EMSH inside M. tuberculosis, while strong acidiﬁcation
leads to oxidized EMSH as measured in phagolysosomes [96]. The
WhiB3 transcription factor senses acidic conditions in the pha-
gosome and activates transcription of WhiB3 regulon genes, such
as type-VII-secretion system eﬀectors (EspA) and polyketide lipids
that inhibit phagosomal maturation. WhiB3 causes up-regulation
of antioxidant systems (MSH, Trx) to restore the redox balance
and to promote survival and persistence of M. tuberculosis inside
the phagosome.
This ﬁgure is adapted from Ref. [96].
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environment induces redox heterogeneity with diﬀerent EMSH sub-po-
pulations in Mtb. Of note, the sub-populations with reduced, oxidized
and basal EMSH were diﬀerent during the time course of infections and
also between various MDR/XDR Mtb isolates indicating a strongly
varying redox balance between Mtb isolates. Immune activation further
leads to an oxidative shift of Mtb sub-populations, which resulted from
NO stress as part of host innate immune defense [95].
Mtb is an intracellular pathogen, that is engulfed by macrophages
and trapped in an organelle, called the phagosome (Fig. 5). Phagosomal
maturation occurs by the interaction of phagosomes with endosomes
and fusion with lysosomes to phagolysosomes, a highly acidic and mi-
crobicidal compartment that ﬁnally degrades invading bacteria [101].
However, Mtb successfully restricts phagosomal maturation by pre-
venting fusion of phagosomes with lysosomes. This enables Mtb to
persist and replicate inside the phagosome to cause chronic and re-
lapsing Mtb infections [102,103]. It was suggested, that the diﬀerent
sub-vacuolar compartments might induce this EMSH redox heterogeneity
in Mtb [95]. The Mtb sub-populations were investigated in diﬀerent
vacuolar compartments including early endosomes, autophagosomes
and lysosomes. Interestingly, the Mtb sub-population located in autop-
hagosome showed almost oxidized EMSH, while those residing in lyso-
somes were 58% oxidized and the sub-population in early endosomes
showed mostly (54%) reduced EMSH. Thus, the biosensor identiﬁed the
sources of redox heterogeneity as the speciﬁc compartments in which
Mtb resides inside macrophages.
2.3.2. Mechanisms of antibiotics-mediated ROS generation as strategy to
combat drug resistance in Mtb
Due to the controversial debate about the role of ROS in antibiotic-
mediated bacterial killing, the changes in intramycobacterial EMSH were
investigated after exposure to anti-TB drugs. In agreement with the
biosensor responses under antibiotics stress in S. Typhimurium and S.
aureus [86,92], no oxidative shift in EMSH was reported in shake-ﬂask
experiments with Mtb populations that were exposed to sub-lethal anti-
TB-drugs, e.g. isoniazide, ethambutol and rifampicin [95]. The only
exception was the redox-cycling drug clofazimine, which caused an
oxidative shift in EMSH in Mtb shake-ﬂask cultures. However, under
macrophage infections, diﬀerent antibiotics classes caused oxidative
stress as shown by an oxidative shift in the EMSH sub-populations, which
was accompanied by increased killing of bacteria. Moreover, the redox
heterogeneous sub-populations vary in their susceptibilities to anti-
biotics. The more oxidized population in autophagosomes and lyso-
somes was more susceptible to antibiotics killing, while the reduced
population in endosomes displayed resistance to anti-TB drugs. Thus,
immune activation inside macrophages potentiates drug killing while
populations with reduced EMSH promote antibiotics tolerance. Together
these results showed important novel insights into the redox hetero-
geneity of Mtb sub-populations in diﬀerent macrophage compartments,
their susceptibility to antibiotics and the mechanisms of persistence
[95].
In subsequent studies, several eﬀorts were undertaken to under-
stand the mechanisms of drug resistance and to develop new ROS-
producing anti-TB drugs. These ROS-generating drug were used alone
and in combination therapies as promising strategy to counteract the
increasing problem of antimicrobial resistance and to combat XDR/
MDR Mtb isolates [97–99]. First, hydroquinone-based antibiotics were
synthesized, including ATD-3169 which was shown to cause superoxide
production in Mtb isolates and increases the irreversible oxidized Mtb
sub-population [99]. Next, combination therapies of isoniazid (INH)
and inhibitors of antioxidant responses were found as promising
strategy to threat drug resistant Mtb isolates [98]. Such inhibitors of
antioxidant responses were ebselen, vancomycin and phenylarsine
oxide that were highly eﬀective in combination with INH to kill drug
resistant Mtb isolates.
INH is a pro-drug that is activated by the catalase KatG and con-
verted to a NAD-INH-adduct, that subsequently inhibits the enoyl-ACP
reductase (InhA) in the mycolic acid biosynthesis pathway [98]. To
identify the mechanisms of drug resistant Mtb strains, isoniazid re-
sistance was studied in more detail in laboratory evolved INH-resistant
M. smegmatis strains [98]. Genome sequencing revealed that INH re-
sistant strains carried point mutations in genes for NADH dehy-
drogenase (ndh), catalase (katG) or the 3-dehydroquinate synthase
(aroB). Transcriptomics identiﬁed antioxidant responses as dominating
in the diﬀerentially transcribed genes in the INH resistant M. smegmatis
strains. Moreover, the INH resistant strain was more sensitive to com-
pounds that block antioxidant responses and disturb EMSH. In agree-
ment with this ﬁnding, the Mrx1-roGFP2 biosensor measurements re-
vealed an oxidized shift in basal EMSH and a higher sensitivity to
oxidative stress by H2O2 in the INH-resistant M. smegmatis strain [98].
This higher ROS-sensitivity was not only observed in the INH-resistant
M. smegmatis strain, but also in clinical MDR and XDR Mtb patient
isolates. Thus, the evolution of drug resistance is associated with
changes in the basal EMSH and shifted to the oxidized redox state in
multiple resistant Mtb isolates. Finally, it was shown that antibiotics
that produce ROS or block antioxidant responses are in combination
with INH more potent to induce oxidative shift in EMSH during infec-
tions. These drugs should be promising strategies to tackle tuberculosis
disease and to combat drug resistant isolates [98].
2.3.3. EMSH regulates the redox state of WhiB4 mediating augmentin
resistance and tolerance
In another study, the mode of action for combination therapy of β-
lactam antibiotics (amoxicillin) with β-lactamase inhibitors (clavula-
nate), termed as augmentin, has been studied. The Mrx1-roGFP2 bio-
sensor revealed a role of EMSH and the WhiB4 redox sensor in aug-
mentin resistance (Fig. 6) [97]. To study the mode of action of
augmentin, a transcriptomics approach was used and identiﬁed cell
wall and oxidative stress responses, respiration and carbon metabolism
induced under augmentin treatment. Using biosensor measurements, an
increase in the oxidized EMSH sub-population was observed by aug-
mentin over time during Mtb infections inside macrophages. Thus,
augmentin eﬀects the redox balance in Mtb, which potentiates its my-
cobactericidal eﬀect and contributes to augmentin killing [97]. Fur-
thermore, MSH was shown to protect Mtb from toxicity under aug-
mentin treatment in survival assays. In further analysis, the FeS-cluster
redox sensor WhiB4 was identiﬁed which regulates the shift to the
oxidized EMSH sub-population after augmentin treatment. Moreover,
this oxidized shift modulates expression of the β-lactamase BlaC, which
is regulated by WhiB4 in a redox-dependent manner. Speciﬁcally, BlaC
is overexpressed in the whiB4 mutant which increases resistance to β-
lactam antibiotics (Fig. 6). In contrast, overexpression of oxidized
WhiB4 under augmentin treatment resulted in strong blaC repression
and increased killing by β-lactams potentiating drug action. Thus,
WhiB4 was identiﬁed as central regulator of β-lactam antibiotics re-
sistance and the oxidative shift in EMSH after augmentin combination
therapy [97].
2.3.4. EMSH regulates the redox state of WhiB3 mediating acid resistance
and inhibition of phagosomal maturation
WhiB3 is another FeS cluster redox sensor that is also regulated by
EMSH and is essential for acid resistance of Mtb which allows survival of
Mtb inside the acidic phagosome upon immune-stimulation
[60,104,105]. WhiB3 was shown to play a protective role together with
MSH under acidic stress conditions inside the phagosome of activated
macrophages (Fig. 5) [96]. WhiB3 mediates acid resistance and inhibits
phagosomal maturation, which is linked to changes in EMSH under in-
fection conditions. WhiB3 controls genes for lipid biosynthesis, secre-
tion of the type-VII-secretion eﬀectors as well as MSH biosynthesis and
recycling under acidic stress. The limited decreased pH upon acid-
iﬁcation of the phagosome (pH ~ 6.2) results in a reductive shift of
EMSH sub-populations and WhiB3 as well as MSH were found as key
regulators for this reductive shift in EMSH. WhiB3 was further required
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for survival under acidic conditions and protectsMtb from acid stress by
controlling genes that restrict phagosomal maturation to subvert acid-
iﬁcation and by down-regulation of the innate immune response. The
whiB3 mutant was also attenuated in the lung of guinea pigs. These
results revealed a link between phagosome acidiﬁcation, the reductive
shift in EMSH and virulence of Mtb that is controlled by WhiB3 med-
iating acid resistance and inhibiting phagosomal maturation as me-
chanism of persistent and chronic Mtb infections [96].
2.3.5. EMSH is controlled by the sulfur assimilation pathway, the membrane
SodA/DoxX/SseA complex and macrophage GSH production that are
required for survival of Mtb
For the treatment of persistent Mtb infections, the sulfur assimila-
tion pathway was selected as promising target that is required for
biosynthesis of sulfur-containing amino acids and thiol-cofactors, such
as cysteine and MSH [106]. The sulfur assimilation pathway, including
the enzyme 5’ adenosine phosphosulfate (APS) reductase (CysH), was
especially important for virulence and survival of Mtb during chronic
and persistent infections in mice and macrophage models [107,108].
Thus, a high-throughput drug screening approach was used to identify
three inhibitors of the APS reductase as potent anti-TB compounds that
decreased the levels of sulfur-containing metabolites, including MSH
[106]. Using the Mrx1-roGFP2 biosensor, an oxidative shift in EMSH was
measured in response to these APS reductase inhibitors indicating the
link between persistence, antibiotic tolerance and the sulfate assimila-
tion pathway in Mtb.
In another study, the Mrx1-roGFP2 biosensor was used to identify
the link between a novel membrane-associated oxidoreductase complex
(MRC) and the MSH redox potential [109]. Using a Tn-seq approach,
the authors screened for interactions of pathways required in Mtb for
detoxiﬁcation of radicals from the phagocyte oxidative burst. The su-
peroxide dismutase (SodA), an integral membrane protein (DoxX) and
the conserved thiol oxidoreductase SseA were identiﬁed as functionally
linked MRC and the electron transfer was veriﬁed in vivo. Single mu-
tants in each MRC component are similar sensitive to radical stress and
exhibited an oxidized EMSH as revealed by Mrx1-roGFP2 biosensor
measurements. This study established a link between a novel oxidative
stress resistance network with the EMSH in Mtb to overcome the oxi-
dative burst during infections [109].
An interaction between macrophage-derived GSH and EMSH during
Mtb infection has been revealed using the Mrx1-roGFP2 biosensor in a
mice model of tuberculosis [110]. The GSH pool of macrophages de-
pends on the xCT cystine-glutamate transporter, which is induced
during Mtb infection. The deletion of xCT resulted in protection against
TB and decreased pulmonary pathology in the mice lung. Mrx1-roGFP2
biosensor measurement revealed an oxidized EMSH of Mtb in the in-
fected mice xCT mutant. The increased EMSH is caused by a decreased
GSH production in the macrophages indicating a link between host GSH
and bacterial MSH redox homeostasis. This study has further identiﬁed
inhibitors of the xCT transporter as host-directed drugs for TB treatment
[110].
Finally, the Mrx1-roGFP2 biosensor was applied in a mycobacterial
bioﬁlms under hypoxic conditions [111]. In the absence of oxygen as
terminal electron acceptor, novel polyketide quinones were produced
as alternative electron carriers in the respiratory chain to maintain
bioenergetics and the membrane potential. About 70% of mycobacterial
cells showed alterations in EMSH under hypoxic bioﬁlm conditions
compared to planktonic cells, including 53% of cells with more reduced
EMSH and 16% with oxidative shift in EMSH. Thus, the diﬀerent oxygen
levels across the bioﬁlm aﬀect the membrane potential and the MSH
redox balance [111].
In summary, the Mrx1-roGFP2 biosensor was approved as valuable
tool to study the mechanisms of redox heterogeneity, persistence and
survival of Mtb under acidic conditions inside macrophage vacuolar
compartments and the evolution and changes in EMSH in drug resistant
Mtb isolates. The biosensor has further contributed to elucidate novel
ROS defense mechanisms in Mtb, such as the radical scavenging
membrane MRC complex and the role of host GSH to regulate the MSH
redox balance of Mtb inside macrophages. In drug research, the bio-
sensor was used to study the regulation and mode of action of combi-
nation therapies (INH and augmentin) involving ROS-generating anti-
biotics as well as novel inhibitors of the sulfate-assimilation pathway as
Fig. 6. The augmentin combination therapy of β-lactam an-
tibiotics and β-lactamase inhibitor (clavulanate) causes ROS
formation and changes in EMSH in Mtb that aﬀect WhiB4-
mediated expression of β-lactamase expression. β-lactam an-
tibiotics inhibit penicillin-binding proteins that cross-link the
peptide side chains of the peptidoglycan (PG). Clavulanate in-
hibits the β-lactamase BlaC in Mtb that is controlled by the BlaI
repressor and WhiB4. The combination therapy of β-lactam and
Clavulanate (Augmentin) causes cell wall stress and ROS pro-
duction in Mtb due to the re-direction of aerobic respiration via
the Ndh2 and CyBD routes [97]. Increased ROS leads to the oxi-
dative shift of EMSH and oxidation of WhiB4 that represses tran-
scription of blaC and the blaI-blaR operon resulting in down-reg-
ulation of the β-lactamase BlaC and killing by augmentin [97].
Tolerance to augmentin is induced by down-regulation or re-
duction of WhiB4 presumable in the reduced EMSH sub-population
resulting in derepression of the β-lactamase-encoding blaC gene
directly or indirectly via derepression of the blaIR operon and
proteolytic degradation of the BlaI repressor by the protease BlaR.
This ﬁgure is adapted from Ref. [97]. Abbreviations: CM: cyto-
plasmic membrane, PG: peptidoglycan, Ndh2: NADH dehy-
drogenase 2, CyBD: cytochrome BD oxidase, PBP: penicillin-
binding protein.
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promising future anti-TB drugs to treat MDR/XDR, persistent and
chronicMtb infections. These main results revealed thus far using Mrx1-
roGFP2 biosensor measurements in Mtb are summarized in the sche-
matics of Fig. 7. Similar mechanisms might be relevant for other in-
tracellular pathogens and persistent bacterial infections. As revealed in
Mtb using the Mrx1-roGFP2 biosensor, redox heterogeneity of the in-
tracellular pathogen S. Typhimurium could be also dependent on sub-
vacuolar compartments. Inside the SCV, S. Typhimurium could be more
tolerant to antibiotics due to a more reduced intrabacterial redox po-
tential, which facilitates the persistent state. In contrast, cytosolic
bacteria should have a more oxidized redox state and should be sus-
ceptible to clinical relevant antibiotics. The mechanisms of persistence
and antibiotics resistance as result of redox heterogeneity remain in-
teresting subject for future studies in redox infection biology.
Acknowledgements
This work was supported by grants from the Deutsche
Forschungsgemeinschaft (AN746/4-1 and AN746/4-2) within the
SPP1710 on “Thiol-based Redox switches” and by the DFG Project C08
within the SFB973 to H.A. Further funding was provided by the DFG
Research Training Group GRK1947, project (C1) and by an ERC
Consolidator Grant (GA 615585) MYCOTHIOLOME to H.A.
Author disclosure statement
No competing ﬁnancial interests exist.
References
[1] K. Van Laer, C.J. Hamilton, J. Messens, Low-molecular-weight thiols in thiol-dis-
ulﬁde exchange, Antioxid. Redox Signal. 18 (2013) 1642–1653.
[2] R.C. Fahey, Glutathione analogs in prokaryotes, Biochim. Biophys. Acta 1830
(2013) 3182–3198.
[3] A.J. Potter, C. Trappetti, J.C. Paton, Streptococcus pneumoniae uses glutathione to
defend against oxidative stress and metal ion toxicity, J. Bacteriol. 194 (2012)
6248–6254.
[4] B. Vergauwen, K. Verstraete, D.B. Senadheera, A. Dansercoer, D.G. Cvitkovitch,
E. Guedon, S.N. Savvides, Molecular and structural basis of glutathione import in
Gram-positive bacteria via GshT and the cystine ABC importer TcyBC of
Streptococcus mutans, Mol. Microbiol. 89 (2013) 288–303.
[5] L. Masip, K. Veeravalli, G. Georgiou, The many faces of glutathione in bacteria,
Antioxid. Redox Signal. 8 (2006) 753–762.
[6] C. Hwang, H.F. Lodish, A.J. Sinskey, Measurement of glutathione redox state in
cytosol and secretory pathway of cultured cells, Methods Enzymol. 251 (1995)
212–221.
[7] I.R. Booth, G.P. Ferguson, S. Miller, C. Li, B. Gunasekera, S. Kinghorn, Bacterial
production of methylglyoxal: a survival strategy or death by misadventure?
Biochem. Soc. Trans. 31 (2003) 1406–1408.
[8] G.P. Ferguson, I.R. Booth, Importance of glutathione for growth and survival of
Escherichia coli cells: detoxiﬁcation of methylglyoxal and maintenance of in-
tracellular K+, J. Bacteriol. 180 (1998) 4314–4318.
[9] G.P. Ferguson, S. Totemeyer, M.J. MacLean, I.R. Booth, Methylglyoxal production
in bacteria: suicide or survival? Arch. Microbiol. 170 (1998) 209–218.
[10] M.J. MacLean, L.S. Ness, G.P. Ferguson, I.R. Booth, The role of glyoxalase I in the
detoxiﬁcation of methylglyoxal and in the activation of the KefB K+ eﬄux system
in Escherichia coli, Mol. Microbiol. 27 (1998) 563–571.
[11] M. Song, M. Husain, J. Jones-Carson, L. Liu, C.A. Henard, A. Vazquez-Torres, Low-
molecular-weight thiol-dependent antioxidant and antinitrosative defences in
Salmonella pathogenesis, Mol. Microbiol. 87 (2013) 609–622.
[12] J. van der Heijden, E.S. Bosman, L.A. Reynolds, B.B. Finlay, Direct measurement of
oxidative and nitrosative stress dynamics in Salmonella inside macrophages, Proc.
Natl. Acad. Sci. USA 112 (2015) 560–565.
[13] M. Hall, C. Grundstrom, A. Begum, M.J. Lindberg, U.H. Sauer, F. Almqvist,
J. Johansson, A.E. Sauer-Eriksson, Structural basis for glutathione-mediated acti-
vation of the virulence regulatory protein PrfA in Listeria, Proc. Natl. Acad. Sci.
USA 113 (2016) 14733–14738.
[14] M.L. Reniere, A.T. Whiteley, K.L. Hamilton, S.M. John, P. Lauer, R.G. Brennan,
D.A. Portnoy, Glutathione activates virulence gene expression of an intracellular
pathogen, Nature 517 (2015) 170–173.
[15] N.E. Freitag, G.C. Port, M.D. Miner, Listeria monocytogenes – from saprophyte to
intracellular pathogen, Nat. Rev. Microbiol. 7 (2009) 623–628.
[16] Y. Wang, H. Feng, Y. Zhu, P. Gao, Structural insights into glutathione-mediated
activation of the master regulator PrfA in Listeria monocytogenes, Protein Cell 8
(2017) 308–312.
[17] J.L. Portman, S.B. Dubensky, B.N. Peterson, A.T. Whiteley, D.A. Portnoy,
Activation of the Listeria monocytogenes virulence program by a reducing en-
vironment, mBio 8 (2017) e01595-17.
[18] J.L. Portman, Q. Huang, M.L. Reniere, A.T. Iavarone, D.A. Portnoy, Activity of the
pore-forming virulence factor listeriolysin O is reversibly inhibited by naturally
occurring S-glutathionylation, Infect. Immun. 85 (2017) e00959-16.
[19] K. McGourty, T.L. Thurston, S.A. Matthews, L. Pinaud, L.J. Mota, D.W. Holden,
Salmonella inhibits retrograde traﬃcking of mannose-6-phosphate receptors and
lysosome function, Science 338 (2012) 963–967.
[20] K. Uchiya, M.A. Barbieri, K. Funato, A.H. Shah, P.D. Stahl, E.A. Groisman, A
Salmonella virulence protein that inhibits cellular traﬃcking, EMBO J. 18 (1999)
3924–3933.
[21] A. Vazquez-Torres, Y. Xu, J. Jones-Carson, D.W. Holden, S.M. Lucia, M.C. Dinauer,
P. Mastroeni, F.C. Fang, Salmonella pathogenicity island 2-dependent evasion of
the phagocyte NADPH oxidase, Science 287 (2000) 1655–1658.
[22] M.M. Marketon, R.W. DePaolo, K.L. DeBord, B. Jabri, O. Schneewind, Plague
bacteria target immune cells during infection, Science 309 (2005) 1739–1741.
Fig. 7. Summary of the EMSH changes in Mtb as
measured using the Mrx1-roGFP2 biosensor. The
genetically encoded Mrx1-roGFP2 biosensor con-
tributed to a deeper understanding of pathogenicity,
survival and anti-tuberculosis drug resistance me-
chanisms as follows: (1) EMSH redox heterogeneity
was shown in Mtb sub-populations that depends on
the location in speciﬁc vacuole compartments [95].
(2) The WhiB3 sensor and EMSH control induction of
type-VII secretion systems and polyketide lipids
under acid conditions in the phagosome to inhibit
phagosomal maturation [96]. (3) The WhiB4 redox
sensor and EMSH control expression of β-lactamase to
induce augmentin tolerance in the reduced Mtb po-
pulation and augmentin killing in the oxidized Mtb
population [97]. (4) Isoniazid (INH) resistant Mtb
isolates have an oxidative EMSH and are highly ROS-
sensitive, while INH-sensitive strains are more re-
sistant to ROS due to a more reduced EMSH [98]. (5)
The membrane-associated oxidoreductase complex
(SodA-DoxX-SseA) regulates radical detoxiﬁcation
and MSH redox balance under infection conditions
[109]. (6) The cystine-glutamate transporter xCT
regulates cystine import into macrophages, resulting
in increased host-GSH biosynthesis and a reduced
EMSH which contributes to TB disease in a mice in-
fection model [110].
Q.N. Tung et al. Free Radical Biology and Medicine 128 (2018) 84–96
94
[23] C.A. Mueller, P. Broz, S.A. Muller, P. Ringler, F. Erne-Brand, I. Sorg, M. Kuhn,
A. Engel, G.R. Cornelis, The V-antigen of Yersinia forms a distinct structure at the
tip of injectisome needles, Science 310 (2005) 674–676.
[24] V.T. Lee, C. Tam, O. Schneewind, LcrV, a substrate for Yersinia enterocolitica type
III secretion, is required for toxin targeting into the cytosol of HeLa cells, J. Biol.
Chem. 275 (2000) 36869–36875.
[25] A. Mitchell, C. Tam, D. Elli, T. Charlton, P. Osei-Owusu, F. Fazlollahi, K.F. Faull,
O. Schneewind, Glutathionylation of Yersinia pestis LcrV and its eﬀects on plague
pathogenesis, mBio 8 (2017).
[26] A. Gaballa, G.L. Newton, H. Antelmann, D. Parsonage, H. Upton, M. Rawat,
A. Claiborne, R.C. Fahey, J.D. Helmann, Biosynthesis and functions of bacillithiol,
a major low-molecular-weight thiol in Bacilli, Proc. Natl. Acad. Sci. USA 107
(2010) 6482–6486.
[27] G.L. Newton, M. Rawat, J.J. La Clair, V.K. Jothivasan, T. Budiarto, C.J. Hamilton,
A. Claiborne, J.D. Helmann, R.C. Fahey, Bacillithiol is an antioxidant thiol pro-
duced in bacilli, Nat. Chem. Biol. 5 (2009) 625–627.
[28] V.V. Loi, M. Rossius, H. Antelmann, Redox regulation by reversible protein S-
thiolation in bacteria, Front. Microbiol. 6 (2015) 187.
[29] A.C. Posada, S.L. Kolar, R.G. Dusi, P. Francois, A.A. Roberts, C.J. Hamilton,
G.Y. Liu, A. Cheung, Importance of bacillithiol in the oxidative stress response of
Staphylococcus aureus, Infect. Immun. 82 (2014) 316–332.
[30] D.C. Pöther, P. Gierok, M. Harms, J. Mostertz, F. Hochgräfe, H. Antelmann,
C.J. Hamilton, I. Borovok, M. Lalk, Y. Aharonowitz, M. Hecker, Distribution and
infection-related functions of bacillithiol in Staphylococcus aureus, Int. J. Med.
Microbiol. 303 (2013) 114–123.
[31] P. Chandrangsu, R. Dusi, C.J. Hamilton, J.D. Helmann, Methylglyoxal resistance in
Bacillus subtilis: contributions of bacillithiol-dependent and independent pathways,
Mol. Microbiol. 91 (2014) 706–715.
[32] Z. Rosario-Cruz, J.M. Boyd, Physiological roles of bacillithiol in intracellular metal
processing, Curr. Genet. 62 (2016) 59–65.
[33] Z. Fang, P.C. Dos Santos, Protective role of bacillithiol in superoxide stress and Fe-
S metabolism in Bacillus subtilis, MicrobiologyOpen 4 (2015) 616–631.
[34] Z. Rosario-Cruz, H.K. Chahal, L.A. Mike, E.P. Skaar, J.M. Boyd, Bacillithiol has a
role in Fe-S cluster biogenesis in Staphylococcus aureus, Mol. Microbiol. 98 (2015)
218–242.
[35] P. Chandrangsu, V.V. Loi, H. Antelmann, J.D. Helmann, The Role of Bacillithiol in
Gram-Positive Firmicutes, Antioxid. Redox Signal. 28 (2018,) 445–462.
[36] S.V. Sharma, M. Arbach, A.A. Roberts, C.J. Macdonald, M. Groom, C.J. Hamilton,
Biophysical features of bacillithiol, the glutathione surrogate of Bacillus subtilis and
other Firmicutes, Chembiochem 14 (2013) 2160–2168.
[37] V.R. Perera, G.L. Newton, K. Pogliano, Bacillithiol: a key protective thiol in
Staphylococcus aureus, Exp. Rev. Anti-Infect. Ther. 13 (2015) 1089–1107.
[38] B.K. Chi, A.A. Roberts, T.T. Huyen, K. Bäsell, D. Becher, D. Albrecht,
C.J. Hamilton, H. Antelmann, S-bacillithiolation protects conserved and essential
proteins against hypochlorite stress in ﬁrmicutes bacteria, Antioxid. Redox Signal.
18 (2013) 1273–1295.
[39] G.L. Newton, R.C. Fahey, M. Rawat, Detoxiﬁcation of toxins by bacillithiol in
Staphylococcus aureus, Microbiology 158 (2012) 1117–1126.
[40] C.C. Winterbourn, A.J. Kettle, Redox reactions and microbial killing in the neu-
trophil phagosome, Antioxid. Redox Signal. 18 (2013) 642–660.
[41] C.C. Winterbourn, A.J. Kettle, M.B. Hampton, Reactive oxygen species and neu-
trophil function, Annu. Rev. Biochem. 85 (2016) 765–792.
[42] J.N. Green, A.L.P. Chapman, C.J. Bishop, C.C. Winterbourn, A.J. Kettle, Neutrophil
granule proteins generate bactericidal ammonia chloramine on reaction with hy-
drogen peroxide, Free Radic. Biol. Med. 113 (2017) 363–371.
[43] M. Imber, N.T.T. Huyen, A.J. Pietrzyk-Brzezinska, V.V. Loi, M. Hillion,
J. Bernhardt, L. Thärichen, K. Kolsek, M. Saleh, C.J. Hamilton, L. Adrian, F. Gräter,
M.C. Wahl, H. Antelmann, Protein S-bacillithiolation functions in thiol protection
and redox regulation of the glyceraldehyde-3-phosphate dehydrogenase gap in
Staphylococcus aureus under hypochlorite stress, Antioxid. Redox Signal. 28
(2018,) 410–430.
[44] N. Brandes, S. Schmitt, U. Jakob, Thiol-based redox switches in eukaryotic pro-
teins, Antioxid. Redox Signal. 11 (2009) 997–1014.
[45] M. Ralser, M.M. Wamelink, A. Kowald, B. Gerisch, G. Heeren, E.A. Struys, E. Klipp,
C. Jakobs, M. Breitenbach, H. Lehrach, S. Krobitsch, Dynamic rerouting of the
carbohydrate ﬂux is key to counteracting oxidative stress, J. Biol. 6 (2007) 10.
[46] Y. Tsuchiya, S.Y. Peak-Chew, C. Newell, S. Miller-Aidoo, S. Mangal, A. Zhyvoloup,
J. Bakovic, O. Malanchuk, G.C. Pereira, V. Kotiadis, G. Szabadkai, M.R. Duchen,
M. Campbell, S.R. Cuenca, A. Vidal-Puig, A.M. James, M.P. Murphy, V. Filonenko,
M. Skehel, I. Gout, Protein CoAlation: a redox-regulated protein modiﬁcation by
coenzyme A in mammalian cells, Biochem. J. 474 (2017) 2489–2508.
[47] A. Gaballa, B.K. Chi, A.A. Roberts, D. Becher, C.J. Hamilton, H. Antelmann,
J.D. Helmann, Redox regulation in Bacillus subtilis: the bacilliredoxins BrxA(YphP)
and BrxB(YqiW) function in de-bacillithiolation of S-bacillithiolated OhrR and
MetE, Antioxid. Redox Signal. 21 (2014) 357–367.
[48] G.L. Newton, N. Buchmeier, R.C. Fahey, Biosynthesis and functions of mycothiol,
the unique protective thiol of Actinobacteria, Microbiol. Mol. Biol. Rev. 72 (2008)
471–494.
[49] V.K. Jothivasan, C.J. Hamilton, Mycothiol: synthesis, biosynthesis and biological
functions of the major low molecular weight thiol in actinomycetes, Nat. Prod.
Rep. 25 (2008) 1091–1117.
[50] N.A. Buchmeier, G.L. Newton, R.C. Fahey, A mycothiol synthase mutant of
Mycobacterium tuberculosis has an altered thiol-disulﬁde content and limited tol-
erance to stress, J. Bacteriol. 188 (2006) 6245–6252.
[51] N.A. Buchmeier, G.L. Newton, T. Koledin, R.C. Fahey, Association of mycothiol
with protection of Mycobacterium tuberculosis from toxic oxidants and antibiotics,
Mol. Microbiol. 47 (2003) 1723–1732.
[52] M. Rawat, C. Johnson, V. Cadiz, Y. Av-Gay, Comparative analysis of mutants in the
mycothiol biosynthesis pathway in Mycobacterium smegmatis, Biochem. Biophys.
Res. Commun. 363 (2007) 71–76.
[53] Y.B. Liu, M.X. Long, Y.J. Yin, M.R. Si, L. Zhang, Z.Q. Lu, Y. Wang, X.H. Shen,
Physiological roles of mycothiol in detoxiﬁcation and tolerance to multiple poi-
sonous chemicals in Corynebacterium glutamicum, Arch. Microbiol. 195 (2013)
419–429.
[54] Q. Zhao, M. Wang, D. Xu, Q. Zhang, W. Liu, Metabolic coupling of two small-
molecule thiols programs the biosynthesis of lincomycin A, Nature 518 (2015)
115–119.
[55] A.M. Reyes, B. Pedre, M.I. De Armas, M.A. Tossounian, R. Radi, J. Messens,
M. Trujillo, Chemistry and redox biology of mycothiol, Antioxid. Redox Signal. 28
(2018,) 487–504.
[56] B.K. Chi, T. Busche, K. Van Laer, K. Basell, D. Becher, L. Clermont, G.M. Seibold,
M. Persicke, J. Kalinowski, J. Messens, H. Antelmann, Protein S-mycothiolation
functions as redox-switch and thiol protection mechanism in Corynebacterium
glutamicum under hypochlorite stress, Antioxid. Redox Signal. 20 (2014) 589–605.
[57] M. Hillion, J. Bernhardt, T. Busche, M. Rossius, S. Maaß, D. Becher, M. Rawat,
M. Wirtz, R. Hell, C. Rückert, J. Kalinowski, H. Antelmann, Monitoring global
protein thiol-oxidation and S-mycothiolation in Mycobacterium smegmatis under
hypochlorite stress using Voronoi redox treemaps, Sci. Rep. (2017).
[58] M. Hillion, M. Imber, B. Pedre, J. Bernhardt, M. Saleh, V.V. Loi, S. Maass,
D. Becher, L. Astolﬁ Rosado, L. Adrian, C. Weise, R. Hell, M. Wirtz, J. Messens,
H. Antelmann, The glyceraldehyde-3-phosphate dehydrogenase GapDH of
Corynebacterium diphtheriae is redox-controlled by protein S-mycothiolation under
oxidative stress, Sci. Rep. 7 (2017) 5020.
[59] G.L. Newton, K. Arnold, M.S. Price, C. Sherrill, S.B. Delcardayre, Y. Aharonowitz,
G. Cohen, J. Davies, R.C. Fahey, C. Davis, Distribution of thiols in microorganisms:
mycothiol is a major thiol in most actinomycetes, J. Bacteriol. 178 (1996)
1990–1995.
[60] V. Saini, B.M. Cumming, L. Guidry, D.A. Lamprecht, J.H. Adamson, V.P. Reddy,
K.C. Chinta, J.H. Mazorodze, J.N. Glasgow, M. Richard-Greenblatt, A. Gomez-
Velasco, H. Bach, Y. Av-Gay, H. Eoh, K. Rhee, A.J.C. Steyn, Ergothioneine main-
tains redox and bioenergetic homeostasis essential for drug susceptibility and
virulence of Mycobacterium tuberculosis, Cell Rep. 14 (2016) 572–585.
[61] C.M. Sassetti, E.J. Rubin, Genetic requirements for mycobacterial survival during
infection, Proc. Natl. Acad. Sci. USA 100 (2003) 12989–12994.
[62] C. Sao Emani, M.J. Williams, I.J. Wiid, N.F. Hiten, A.J. Viljoen, R.D. Pietersen,
P.D. van Helden, B. Baker, Ergothioneine is a secreted antioxidant in
Mycobacterium smegmatis, Antimicrob. Agents Chemother. 57 (2013) 3202–3207.
[63] P. Ta, N. Buchmeier, G.L. Newton, M. Rawat, R.C. Fahey, Organic hydroperoxide
resistance protein and ergothioneine compensate for loss of mycothiol in
Mycobacterium smegmatis mutants, J. Bacteriol. 193 (2011) 1981–1990.
[64] M.A. Tossounian, B. Pedre, K. Wahni, H. Erdogan, D. Vertommen, I. Van Molle,
J. Messens, Corynebacterium diphtheriae methionine sulfoxide reductase a exploits
a unique mycothiol redox relay mechanism, J. Biol. Chem. 290 (2015)
11365–11375.
[65] B. Pedre, I. Van Molle, A.F. Villadangos, K. Wahni, D. Vertommen, L. Turell,
H. Erdogan, L.M. Mateos, J. Messens, The Corynebacterium glutamicum mycothiol
peroxidase is a reactive oxygen species-scavenging enzyme that shows promiscuity
in thiol redox control, Mol. Microbiol. 96 (2015) 1176–1191.
[66] M. Hugo, K. Van Laer, A.M. Reyes, D. Vertommen, J. Messens, R. Radi, M. Trujillo,
Mycothiol/mycoredoxin 1-dependent reduction of the peroxiredoxin AhpE from
Mycobacterium tuberculosis, J. Biol. Chem. 289 (2014) 5228–5239.
[67] Y. Liu, X. Yang, Y. Yin, J. Lin, C. Chen, J. Pan, M. Si, X. Shen, Mycothiol protects
Corynebacterium glutamicum against acid stress via maintaining intracellular pH
homeostasis, scavenging ROS, and S-mycothiolating MetE, J. Gen. Appl.
Microbiol. 62 (2016) 144–153.
[68] D. Sareen, G.L. Newton, R.C. Fahey, N.A. Buchmeier, Mycothiol is essential for
growth ofMycobacterium tuberculosis Erdman, J. Bacteriol. 185 (2003) 6736–6740.
[69] Z. Ma, C. Lienhardt, H. McIlleron, A.J. Nunn, X. Wang, Global tuberculosis drug
development pipeline: the need and the reality, Lancet 375 (2010) 2100–2109.
[70] M.H. Hazbon, M. Brimacombe, M. Bobadilla del Valle, M. Cavatore, M.I. Guerrero,
M. Varma-Basil, H. Billman-Jacobe, C. Lavender, J. Fyfe, L. Garcia-Garcia,
C.I. Leon, M. Bose, F. Chaves, M. Murray, K.D. Eisenach, J. Sifuentes-Osornio,
M.D. Cave, A. Ponce de Leon, D. Alland, Population genetics study of isoniazid
resistance mutations and evolution of multidrug-resistant Mycobacterium tubercu-
losis, Antimicrob. Agents Chemother. 50 (2006) 2640–2649.
[71] R. Rawat, A. Whitty, P.J. Tonge, The isoniazid-NAD adduct is a slow, tight-binding
inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct aﬃnity
and drug resistance, Proc. Natl. Acad. Sci. USA 100 (2003) 13881–13886.
[72] S.S. Nilewar, M.K. Kathiravan, Mycothiol: a promising antitubercular target,
Bioorg. Chem. 52 (2014) 62–68.
[73] M. Schwarzlander, T.P. Dick, A.J. Meyer, B. Morgan, Dissecting redox biology
using ﬂuorescent protein sensors, Antioxid. Redox Signal. 24 (2016) 680–712.
[74] A.J. Meyer, T.P. Dick, Fluorescent protein-based redox probes, Antioxid. Redox
Signal. 13 (2010) 621–650.
[75] M. Gutscher, A.L. Pauleau, L. Marty, T. Brach, G.H. Wabnitz, Y. Samstag,
A.J. Meyer, T.P. Dick, Real-time imaging of the intracellular glutathione redox
potential, Nat. Methods 5 (2008) 553–559.
[76] D.S. Bilan, V.V. Belousov, New tools for redox biology: from imaging to manip-
ulation, Free Radic. Biol. Med. 109 (2017) 167–188.
[77] B. Morgan, M.C. Sobotta, T.P. Dick, Measuring E(GSH) and H2O2 with roGFP2-
based redox probes, Free Radic. Biol. Med. 51 (2011) 1943–1951.
[78] A.J. Meyer, T. Brach, L. Marty, S. Kreye, N. Rouhier, J.P. Jacquot, R. Hell,
Q.N. Tung et al. Free Radical Biology and Medicine 128 (2018) 84–96
95
Redox‐sensitive GFP in Arabidopsis thaliana is a quantitative biosensor for the
redox potential of the cellular glutathione redox buﬀer, Plant J. 52 (2007)
973–986.
[79] P. Back, W.H. De Vos, G.G. Depuydt, F. Matthijssens, J.R. Vanﬂeteren,
B.P. Braeckman, Exploring real-time in vivo redox biology of developing and aging
Caenorhabditis elegans, Free Radic. Biol. Med. 52 (2012) 850–859.
[80] D. Kasozi, F. Mohring, S. Rahlfs, A.J. Meyer, K. Becker, Real-time imaging of the
intracellular glutathione redox potential in the malaria parasite Plasmodium fal-
ciparum, PLoS Pathog. 9 (2013) e1003782.
[81] C.R. Arias-Barreiro, K. Okazaki, A. Koutsaftis, S.H. Inayat-Hussain, A. Tani,
M. Katsuhara, K. Kimbara, I.C. Mori, A bacterial biosensor for oxidative stress
using the constitutively expressed redox-sensitive protein roGFP2, Sensors 10
(2010) 6290–6306.
[82] G.T. Hanson, R. Aggeler, D. Oglesbee, M. Cannon, R.A. Capaldi, R.Y. Tsien,
S.J. Remington, Investigating mitochondrial redox potential with redox-sensitive
green ﬂuorescent protein indicators, J. Biol. Chem. 279 (2004) 13044–13053.
[83] L. Ooi, L.Y. Heng, I.C. Mori, A high-throughput oxidative stress biosensor based on
Escherichia coli roGFP2 cells immobilized in a k-carrageenan matrix, Sensors 15
(2015) 2354–2368.
[84] J.A. Imlay, The molecular mechanisms and physiological consequences of oxida-
tive stress: lessons from a model bacterium, Nat. Rev. Microbiol. 11 (2013)
443–454.
[85] S. Mishra, J. Imlay, Why do bacteria use so many enzymes to scavenge hydrogen
peroxide? Arch. Biochem. Biophys. 525 (2012) 145–160.
[86] J. van der Heijden, S.L. Vogt, L.A. Reynolds, J. Pena-Diaz, A. Tupin, L. Aussel,
B.B. Finlay, Exploring the redox balance inside gram-negative bacteria with redox-
sensitive GFP, Free Radic. Biol. Med. 91 (2016) 34–44.
[87] M.A. Kohanski, D.J. Dwyer, B. Hayete, C.A. Lawrence, J.J. Collins, A common
mechanism of cellular death induced by bactericidal antibiotics, Cell 130 (2007)
797–810.
[88] Y. Liu, J.A. Imlay, Cell death from antibiotics without the involvement of reactive
oxygen species, Science 339 (2013) 1210–1213.
[89] I. Keren, Y. Wu, J. Inocencio, L.R. Mulcahy, K. Lewis, Killing by bactericidal an-
tibiotics does not depend on reactive oxygen species, Science 339 (2013)
1213–1216.
[90] P. Shukla, V.S. Khodade, M. SharathChandra, P. Chauhan, S. Mishra,
S. Siddaramappa, B.E. Pradeep, A. Singh, H. Chakrapani, "On demand" redox
buﬀering by H2S contributes to antibiotic resistance revealed by a bacteria-spe-
ciﬁc H2S donor, Chem. Sci. 8 (2017) 4967–4972.
[91] J. van der Heijden, L.A. Reynolds, W. Deng, A. Mills, R. Scholz, K. Imami,
L.J. Foster, F. Duong, B.B. Finlay, Salmonella rapidly regulates membrane per-
meability to survive oxidative stress, mBio 7 (2016) e01238–01216.
[92] V.V. Loi, M. Harms, M. Müller, N.T.T. Huyen, C.J. Hamilton, F. Hochgräfe, J. Pane-
Farre, H. Antelmann, Real-time imaging of the bacillithiol redox potential in the
human pathogen Staphylococcus aureus using a genetically encoded bacilliredoxin-
fused redox biosensor, Antioxid. Redox Signal. 26 (2017) 835–848.
[93] B.A. Diep, S.R. Gill, R.F. Chang, T.H. Phan, J.H. Chen, M.G. Davidson, F. Lin,
J. Lin, H.A. Carleton, E.F. Mongodin, G.F. Sensabaugh, F. Perdreau-Remington,
Complete genome sequence of USA300, an epidemic clone of community-acquired
meticillin-resistant Staphylococcus aureus, Lancet 367 (2006) 731–739.
[94] H. Weber, S. Engelmann, D. Becher, M. Hecker, Oxidative stress triggers thiol
oxidation in the glyceraldehyde-3-phosphate dehydrogenase of Staphylococcus
aureus, Mol. Microbiol. 52 (2004) 133–140.
[95] A. Bhaskar, M. Chawla, M. Mehta, P. Parikh, P. Chandra, D. Bhave, D. Kumar,
K.S. Carroll, A. Singh, Reengineering redox sensitive GFP to measure mycothiol
redox potential of Mycobacterium tuberculosis during infection, PLoS Pathog. 10
(2014) e1003902.
[96] M. Mehta, R.S. Rajmani, A. Singh, Mycobacterium tuberculosis WhiB3 responds to
vacuolar pH-induced changes in mycothiol redox potential to modulate phago-
somal maturation and virulence, J. Biol. Chem. 291 (2016) 2888–2903.
[97] S. Mishra, P. Shukla, A. Bhaskar, K. Anand, P. Baloni, R.K. Jha, A. Mohan,
R.S. Rajmani, V. Nagaraja, N. Chandra, A. Singh, Eﬃcacy of beta-lactam/beta-
lactamase inhibitor combination is linked to WhiB4-mediated changes in redox
physiology of Mycobacterium tuberculosis, Elife 6 (2017) e25624.
[98] J. Padiadpu, P. Baloni, K. Anand, M. Munshi, C. Thakur, A. Mohan, A. Singh,
N. Chandra, Identifying and tackling emergent vulnerability in drug-resistant
mycobacteria, ACS Infect. Dis. 2 (2016), pp. 592–607.
[99] P. Tyagi, A.T. Dharmaraja, A. Bhaskar, H. Chakrapani, A. Singh, Mycobacterium
tuberculosis has diminished capacity to counteract redox stress induced by elevated
levels of endogenous superoxide, Free Radic. Biol. Med. 84 (2015) 344–354.
[100] K.S. Ung, Y. Av-Gay, Mycothiol-dependent mycobacterial response to oxidative
stress, FEBS Lett. 580 (2006) 2712–2716.
[101] V. Poirier, Y. Av-Gay, Intracellular growth of bacterial pathogens: the role of se-
creted eﬀector proteins in the control of phagocytosed microorganisms, Microbiol.
Spectr. 3 (2015).
[102] S. Ehrt, D. Schnappinger, Mycobacterial survival strategies in the phagosome:
defence against host stresses, Cell Microbiol. 11 (2009) 1170–1178.
[103] D. Schnappinger, S. Ehrt, M.I. Voskuil, Y. Liu, J.A. Mangan, I.M. Monahan,
G. Dolganov, B. Efron, P.D. Butcher, C. Nathan, G.K. Schoolnik, Transcriptional
adaptation of Mycobacterium tuberculosis within macrophages: insights into the
phagosomal environment, J. Exp. Med. 198 (2003) 693–704.
[104] G.B. Coulson, B.K. Johnson, H. Zheng, C.J. Colvin, R.J. Fillinger, E.R. Haiderer,
N.D. Hammer, R.B. Abramovitch, Targeting Mycobacterium tuberculosis sensitivity
to thiol stress at acidic pH kills the bacterium and potentiates antibiotics, Cell
Chem. Biol. 24 (2017) 993–1004 (e1004).
[105] A. Singh, L. Guidry, K.V. Narasimhulu, D. Mai, J. Trombley, K.E. Redding,
G.I. Giles, J.R. Lancaster Jr, A.J. Steyn,Mycobacterium tuberculosisWhiB3 responds
to O2 and nitric oxide via its [4Fe-4S] cluster and is essential for nutrient star-
vation survival, Proc. Natl. Acad. Sci. USA 104 (2007) 11562–11567.
[106] P.B. Palde, A. Bhaskar, L.E. Pedro Rosa, F. Madoux, P. Chase, V. Gupta, T. Spicer,
L. Scampavia, A. Singh, K.S. Carroll, First-in-class inhibitors of sulfur metabolism
with bactericidal activity against non-replicating M. tuberculosis, ACS Chem. Biol.
11 (2016) 172–184.
[107] J. Rengarajan, B.R. Bloom, E.J. Rubin, Genome-wide requirements for
Mycobacterium tuberculosis adaptation and survival in macrophages, Proc. Natl.
Acad. Sci. USA 102 (2005) 8327–8332.
[108] R.H. Senaratne, A.D. De Silva, S.J. Williams, J.D. Mougous, J.R. Reader, T. Zhang,
S. Chan, B. Sidders, D.H. Lee, J. Chan, C.R. Bertozzi, L.W. Riley, 5'-
Adenosinephosphosulphate reductase (CysH) protects Mycobacterium tuberculosis
against free radicals during chronic infection phase in mice, Mol. Microbiol. 59
(2006) 1744–1753.
[109] S. Nambi, J.E. Long, B.B. Mishra, R. Baker, K.C. Murphy, A.J. Olive, H.P. Nguyen,
S.A. Shaﬀer, C.M. Sassetti, The oxidative stress network of Mycobacterium tu-
berculosis reveals coordination between radical detoxiﬁcation systems, Cell Host
Microbe 17 (2015) 829–837.
[110] Y. Cai, Q. Yang, M. Liao, H. Wang, C. Zhang, S. Nambi, W. Wang, M. Zhang, J. Wu,
G. Deng, Q. Deng, H. Liu, B. Zhou, Q. Jin, C.G. Feng, C.M. Sassetti, F. Wang,
X. Chen, xCT increases tuberculosis susceptibility by regulating antimicrobial
function and inﬂammation, Oncotarget 7 (2016) 31001–31013.
[111] A. Anand, P. Verma, A.K. Singh, S. Kaushik, R. Pandey, C. Shi, H. Kaur, M. Chawla,
C.K. Elechalawar, D. Kumar, Y. Yang, N.S. Bhavesh, R. Banerjee, D. Dash, A. Singh,
V.T. Natarajan, A.K. Ojha, C.C. Aldrich, R.S. Gokhale, Polyketide quinones are
alternate intermediate electron carriers during mycobacterial respiration in
oxygen-deﬁcient niches, Mol. Cell 60 (2015) 637–650.
Q.N. Tung et al. Free Radical Biology and Medicine 128 (2018) 84–96
96
